- £23.65bn
- £24.28bn
- £5.59bn
Annual income statement for 3i, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,194 | 4,777 | 4,011 | 5,155 | 5,587 |
| Cost of Revenue | |||||
| Gross Profit | 4,148 | 4,739 | 3,960 | 5,141 | 5,582 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 176 | 202 | 173 | 116 | 294 |
| Operating Profit | 4,018 | 4,575 | 3,838 | 5,039 | 5,293 |
| Net Income Before Taxes | 4,018 | 4,575 | 3,838 | 5,039 | 5,293 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4,013 | 4,573 | 3,836 | 5,038 | 5,294 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4,013 | 4,573 | 3,836 | 5,038 | 5,294 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4,013 | 4,573 | 3,836 | 5,038 | 5,294 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.14 | 4.74 | 3.97 | 5.21 | 5.19 |
| Dividends per Share |